Fisher symposium on future directions in Alzheimer's disease. An editorial introduction

TY - JOUR

T1 - Fisher symposium on future directions in Alzheimer's disease. An editorial introduction

AU - Coleman, Paul D.

N1 - Funding Information: The following papers represent the output of the Fisher Symposium on Future Directions in Alzheimer's Disease, held in Washington, DC, May 24-26, 1994, under the auspices of the National Institute on Aging and with the support of the Zachary and Elizabeth M. Fisher Medical Foundation. The purpose of the Conference was to aid in defining a national agenda toward the development of effective, rational treatment of Alzheimer's disease. The urgency of developing an effective treatment for Alzheimer's disease is emphasized by the 4 million persons affected by the disease, and by the national cost of this disease totalling $100 billion annually. The Conference was attended by an international panel of invited participants each of whom contributed a brief position statement well ahead of the Conference. These statements were distributed to all participants before the Conference took place, and formed the basis for further discussion. Most discussion took place in three subgroups chaired by Carl Cotman, Stanley Prusiner, and Paul Coleman. At the end of the Conference each of the three Discussion Chairs presented a report of their group's discussion to the Conference as a whole. These reports were accompanied by animated discussion which influenced the final, written report of the three Chairs. The format of this issue of Neurobiology of Aging departs from the usual format of the Journal in several ways. Summary reports from each of the Discussion Group Leaders are presented following introductory materials from President Clinton, Hillary Rodham Clinton, Zachary Fisher, Bijan Safai, and Zaven Khachaturian (Guest Editor). The reports of the discussion groups are then followed by the individual position papers of the invited participants. The papers presented here have not been refereed, on the grounds that they represent opinions of selected leaders in Alzheimer's Disease research. The material presented here should be considered in that light.

PY - 1994

Y1 - 1994

UR - http://www.scopus.com/inward/record.url?scp=0028088747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028088747&partnerID=8YFLogxK

U2 - 10.1016/0197-4580(94)90155-4

DO - 10.1016/0197-4580(94)90155-4

M3 - Article

C2 - 7700428

AN - SCOPUS:0028088747

SN - 0197-4580

VL - 15

SP - 1

JO - Neurobiology of Aging

JF - Neurobiology of Aging

IS - SUPPL. 2

ER -